Navigation Links
A Non-profit Drug Firms Injection to Fight Kala Azar Included in WHOs Model List

icines based on its quality, safety and efficacy standards. The WHO List of Essential Medicines helps governments address problems of cost and availability and provides guidance to the pharmaceutical industry on medicine needs globally.

The decision was made at the 15th Expert Committee on the Selection and Use of Essential Medicines, which met in Geneva earlier this year. In its letter notifying OneWorld Health of its decision, the WHO noted that, Paromomycin appears to be the most cost-effective treatment among all available alternatives.

The inclusion of OneWorld Healths first approved drug product on the WHO Essential Medicines List recognizes the value of Paromomycin IM Injection to combat this lethal disease. This recognition is an important step in the realization of our drug development mission: Bringing the promise of safe, effective, and affordable medicines to those most in need, said Dr. Ahvie Herskowitz, OneWorld Healths Co-founder and Chief Medical Officer.

Gland Pharma Limited, the Hyderabad, India-based drug manufacturer working with OneWorld Health and its collaborators, received regulatory approval from the Drug-Controller General - India (DCGI) for Paromomycin IM Injection as a treatment for VL on August 31, 2006. Gland has committed to act as the low cost global manufacturer to ensure access of Paromomycin to all those that need it.

WHO first published the first Model List of Essential Drugs in 1977, identifying 208 individual medicines that together could provide safe, effective treatment for the majority of communicable and non-communicable diseases. Essential medicines are intended to be available within the context of functioning health systems at all times in adequate amounts, in the appropriate dosage forms, with assured quality and adequate information, and at a price the individual and the community can afford.

Many international organizations, including UNICEF and the
'"/>




Page: 1 2 3

Related medicine news :

1. Firms Told To Employ Those With Aspergers Syndrome
2. Drug Firms To Produce Single Pill AIDS Treatment
3. 12 Chinese Firms Appeal Against Court Ruling On Viagra
4. Drug Firms Meet Annan, Pledge on AIDS Medicines
5. Drug Firms Competing to Produce Cheap and Effective bird flu vaccine
6. US, India Firms Develop New Cure for Black Fever
7. Chemical Firms are Secretly Paying Scientists
8. Supreme Court Seeks Replies From Cola Firms
9. Nexus Between Psychiatrists and Drug Firms Dangerous, Say Critics
10. Injection supports Heart Devices
11. Abstinence From Alcohol With The Help Of An Injection
Post Your Comments:
(Date:12/2/2008)...ll/ -- Quest Diagnostics Incorporated (NYSE: DGX...ting, information and services, announced that it ...are Conference in New York City today, December 2,...duled to begin at 4:00 p.m. Eastern Time. , ...irm its 2008 guidance for revenue growth of greate...
(Date:12/2/2008)... December 1, 2008, issue of Clinical Cancer Resea...ncer Research, show lapatinib benefits women with ...-negative breast cancer or those who express EGRF ...a misclassification of metastatic breast cancer pa...le from receiving optimal therapy. , Lapatinib,...
(Date:12/2/2008)..., Cost and Energy Efficient Information Infrastruc...re/ -- EMC Corporation (NYSE: EMC ), the world l...ay announced that the Daughters of Charity Health ...spanning the California coast, has consolidated st...ity functions to deliver new online clinical syste...
(Date:12/2/2008)...Emdeon, a leading provider of,revenue and payment...ustry,announced today the launch of an important...are. Emdeon unveiled the U.S. Healthcare Efficienc...blish a national reference for,tracking and measu...ased,system to an electronic one. , "Throu...
Breaking Medicine News(10 mins):Health News:Quest Diagnostics to Speak at the 20th Annual Piper Jaffray Healthcare Conference 2Health News:HER2 levels may aid in treatment selection for metastatic breast cancer 2Health News:Daughters of Charity Health System Improves IT Efficiency and Accelerates Time-to-Treatment with EMC 2Health News:Daughters of Charity Health System Improves IT Efficiency and Accelerates Time-to-Treatment with EMC 3Health News:Daughters of Charity Health System Improves IT Efficiency and Accelerates Time-to-Treatment with EMC 4Health News:Emdeon Convenes Industry Forum to Monitor Business Efficiency in Healthcare 2Health News:Emdeon Convenes Industry Forum to Monitor Business Efficiency in Healthcare 3Health News:Emdeon Convenes Industry Forum to Monitor Business Efficiency in Healthcare 4
...ple in a Tamil Nadu village and over 60 doctors ar...tes complications.// A medical technology company,... with the Tirunelveli Medical College at the Ariya...ere. "At present, there is little testing done to...
...have been on an all time high in the United Kingdo...n the rising temperature and pollution levels. //A...iod from 15th to 19th July, the temperatures were ...gen dioxide pollution, which is known to trigger a...
...n their way home after a month-long training in tr...nt in India will surely help improve life in war-t...mastered will help my people in Iraq," Wafa Esmaee...from Bangalore, where she was among 43 Iraqis who ...
...n developed by Georgia Tech researchers to decode ...s with other cells and reacts //to a broad spectru...ld help to better create drugs that are capable of...g human diseases. Most sophisticated tools curren...
Other Medicine News:Health News:Villagers in Tamil Nadu Take Part in Diabetes Pilot Project 2Health News:Sensor Images Show Soaring Temperature and Pollution Levels in UK 2Health News:Yoga and Meditation Comes in Aid of Iraqis to Rid of Trauma 2Health News:Yoga and Meditation Comes in Aid of Iraqis to Rid of Trauma 3Health News:Cell Behavior Better Understood with Nano Probe 2Health News:Cell Behavior Better Understood with Nano Probe 3
(Date:11/26/2008)...26 Children whose eyes ...tly increased risk of developing mental illness by... Clinic study published this month in Pediatrics ,...ediatrics. , , The retrospective study exam...bismus (misaligned eyes) and compared them with re...
(Date:11/25/2008)...5 Kleinert Kutz and Un...e fifth U.S. hand transplant on Messina, New York ...ish Hospital Hand Care Center on Monday, November ...d was completed shortly after 9 p.m. in a record n....com/cgi-bin/prnh/20081125/DC48555-a ) , (Photo...
(Date:11/25/2008)... 25 Pharmacyclics, Inc.,...y has completed a Phase 1,clinical trial with PCI...-molecule Factor VIIa inhibitor. The trial was con...uate the safety and pharmacologic effect of,PCI-2...d in a linear dose,response in the International ...
(Date:11/24/2008)...24 Domino,s Pizza (NYSE: DPZ ), ... gearing up to raise dough for,the kids of St. Ju...nnual,Thanks and Giving campaign. Domino,s custom...at point of purchase to benefit the children of St...the phone or when ordering online at, www.dominos...
Breaking Medicine Technology:Eye Divergence in Children Triples Risk of Mental Illness 2Kleinert Kutz Hand Surgeons Perform Fifth U.S. Hand Transplant in Record Time at Jewish Hospital Hand Care Center 2Kleinert Kutz Hand Surgeons Perform Fifth U.S. Hand Transplant in Record Time at Jewish Hospital Hand Care Center 3Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 2Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 3Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 4Domino's Pizza Pledges Support to the Fifth Annual St. Jude Children's Research Hospital(R) Thanks and Giving(R) Campaign 2Domino's Pizza Pledges Support to the Fifth Annual St. Jude Children's Research Hospital(R) Thanks and Giving(R) Campaign 3Study fuels debate over whether exercise and body size influence ovarian cancer risk 2180 1Study fuels debate over whether exercise and body size influence ovarian cancer risk 2180 2Study fuels debate over whether exercise and body size influence ovarian cancer risk 2180 3Susan G Komen for the Cure Partners With the Original Butter Bell 28R 29 Crock Developer 2176 1Susan G Komen for the Cure Partners With the Original Butter Bell 28R 29 Crock Developer 2176 2New Report Says a Pandemic is Overdue But Companies and Nations are ill Prepared to Cope With the Impact 2173 1New Report Says a Pandemic is Overdue But Companies and Nations are ill Prepared to Cope With the Impact 2173 2New Report Says a Pandemic is Overdue But Companies and Nations are ill Prepared to Cope With the Impact 2173 3New Report Says a Pandemic is Overdue But Companies and Nations are ill Prepared to Cope With the Impact 2173 4New Report Says a Pandemic is Overdue But Companies and Nations are ill Prepared to Cope With the Impact 2173 5Kensey Nash Reports Acceleration of Stock Awards Triggered by Shareholder Acquisition of Greater Than 20 25 of Outstanding Shares 2170 1Kensey Nash Reports Acceleration of Stock Awards Triggered by Shareholder Acquisition of Greater Than 20 25 of Outstanding Shares 2170 2Kensey Nash Reports Acceleration of Stock Awards Triggered by Shareholder Acquisition of Greater Than 20 25 of Outstanding Shares 2170 3Kensey Nash Reports Acceleration of Stock Awards Triggered by Shareholder Acquisition of Greater Than 20 25 of Outstanding Shares 2170 4
...s.--(BUSINESS WIRE)--Apr 12, 2007 - CombinatoRx,I...osters related,to its oncology research efforts wi...American Association for Cancer Research,April 14...ng of Targeted Chemical Combinations for,Cancer Th...resented,on Sunday, April 15, 1-5pm PT and "Synerg...
...ion pyridopyrazine-urea derivative compound series... be valuable for,cancer treatment, QUEBEC, April 1...Inc. , a global, pure play biopharmaceutical compa...y presented an abstract,outlining first in vitro d...lectivity for PI3K inhibition, at the American,Ass...
Other Medicine Technology:CombinatoRx to Present Combination High Throughput Screening (cHTS),Data at Upcoming AACR Meeting 2CombinatoRx to Present Combination High Throughput Screening (cHTS),Data at Upcoming AACR Meeting 3AEterna Zentaris Discloses First In Vitro Data for its PI3K,Inhibitors at the AACR Annual Meeting in Los Angeles 2AEterna Zentaris Discloses First In Vitro Data for its PI3K,Inhibitors at the AACR Annual Meeting in Los Angeles 3
These precision 4mL PYREX volumetric pipets are manufactured and calibrated "To Contain" (TC - bottom line) and "To Deliver" (TD - top line) to specifications for Class A volumetric ware. Pipets are
The new Finnpipette Focus from Thermo Labsystems was designed specifically to combine ergonomics with uncompromising performance. The new interchangeable handle plate offers a custom fit for differe
Inquire
A fixed pipette is ideal for repeated pipetting of a single volume. Fixed volume FInnpipettes offer the same features and advantages as other Finnpipette Digital pipettes: New, streamlined design, S
Medicine Products: